Delayed radical prostatectomy due to COVID-19 does not lead to adverse oncologic outcomes
08 Oct 2020
byStephen Padilla
Delays in radical prostatectomy due to the novel coronavirus disease (COVID-19) pandemic does not result in adverse pathology, upgrading, nodal metastasis, or use of postsurgery secondary treatments, according to a recent study.